Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Effect of short-term treatment with recombinant human growth hormone on lipids and lipoproteins in women and men without growth hormone disturbances.

Hansen PS, Kassem M, Brixen K, Klausen IC, Mosekilde L, Faergeman O.

Metabolism. 1995 Jun;44(6):725-9.

PMID:
7783656
2.

Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.

Cuneo RC, Salomon F, Watts GF, Hesp R, Sönksen PH.

Metabolism. 1993 Dec;42(12):1519-23.

PMID:
8246764
4.

The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients.

Russell-Jones DL, Watts GF, Weissberger A, Naoumova R, Myers J, Thompson GR, Sönksen PH.

Clin Endocrinol (Oxf). 1994 Sep;41(3):345-50.

PMID:
7955441
5.

Effects of growth hormone on serum lipids and lipoproteins: possible significance of increased peripheral conversion of thyroxine to triiodothyronine.

Wolthers T, Lemming L, Grøfte T, Møller N, Christiansen JS, Klausen IC, Jørgensen JO.

Metabolism. 1996 Aug;45(8):1016-20.

PMID:
8769362
6.

Effect of short-term recombinant growth hormone administration on plasma lipoproteins in elderly adults.

Angelopoulos TJ, Seip RL, Cole TG.

Gerontology. 1998;44(4):228-31.

PMID:
9657084
7.

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH.

Br J Sports Med. 2004 Jun;38(3):253-9.

8.

Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.

Oscarsson J, Ottosson M, Wiklund O, Mårin P, Vikman-Adolfsson K, Björntorp P, Edén S.

Clin Endocrinol (Oxf). 1994 Jul;41(1):109-16.

PMID:
8050123
9.

Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.

Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.

Ren Fail. 2006;28(7):567-71.

PMID:
17050239
10.
11.

Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.

Menys VC, Liu Y, Mackness MI, Caslake MJ, Kwok S, Durrington PN.

Clin Chim Acta. 2003 Aug;334(1-2):95-106.

PMID:
12867279
12.

Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.

Weltman A, Despres JP, Clasey JL, Weltman JY, Wideman L, Kanaley J, Patrie J, Bergeron J, Thorner MO, Bouchard C, Hartman ML.

Metabolism. 2003 Jan;52(1):73-80.

PMID:
12524665
13.

Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.

Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, Schnohr P, Tybjaerg-Hansen A.

J Lipid Res. 2000 Nov;41(11):1812-22.

14.

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.

Gynecol Endocrinol. 2004 May;18(5):244-57.

PMID:
15346660
15.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W; Atherosclerosis Risk in Communities Study Group..

Circulation. 2001 Sep 4;104(10):1108-13.

16.

Short and long-term effects of growth hormone treatment on lipid, lipoprotein, and apolipoprotein levels in short normal children.

Azzarito C, Boiardi L, Zini M, Agosti A, Biacchessi M, Biagi R, Portioli I.

Horm Metab Res. 1994 Sep;26(9):432-5.

PMID:
7835828
18.

Supplemental Content

Support Center